Dear Colleagues, BioRxiv is the new home to pre-print publications for all disciplines involved in clinical drug development and therapeutics! Check out the new Drug Development and Clinical Therapeutics <http://connect.biorxiv.org/relate/content/52> (#ddct) channel on the well-know BioRxiv <http://biorxiv.org/> pre-print site (channels are listed in a menu on the upper right side of the main page).
Pre-prints provide rapid dissemination of knowledge with an opportunity to receive dynamic and continuous feedback from multiple reviewers that can improve the quality of your publication. We believe pre-prints are an essential but missing link in our rapidly growing field of quantitative clinical sciences that support clinical drug development and therapeutic management. You can learn more about pre-prints <https://www.youtube.com/watch?v=2zMgY8Dx9co> and Biorxiv <https://www.youtube.com/watch?v=EwAMtT3ZIpg> by watching the videos in the links. Submitting your manuscripts to biorxiv’s #ddct channel requires 2 simple steps: 1. Submit your manuscript through the regular submission route of biorxiv that can be found here <http://biorxiv.org/submit-a-manuscript> 2. Add a #ddct Tag to the end of your manuscript abstract to get listed in the Drug Development and Clinical Therapeutics channel <http://connect.biorxiv.org/relate/content/52>. In addition to this tag, you can include multiple other tags that are listed here <http://connect.biorxiv.org/relate/content/52> in the “Instructions for authors” Your manuscript will be sent out to moderators who will oversee the content and approve the pre-print. The moderator’s job is primarily to ensure that the manuscript is a rigorous scientific work in an area consistent with the scope of the #ddct channel. Review of the details of the manuscript is left to the community who have access to a discussion board for each manuscript. This will facilitate an open peer review process designed to help authors improve their work before submitting to a peer-reviewed journal. A revised and refined manuscript after open peer-review can still be submitted to any standard journal of your choice. We are seeking moderators from different time zones around the world, at least 1-2 from each continent. Moderators will serve for a one year term at the end of which can nominate other colleagues to serve. If you would like to nominate yourself or a colleague, please send an email to the contacts listed below with the subject line - “Intent to moderate #ddct biorxiv”. Please send all questions and comments to - Vijay Ivaturi - ivijayd...@gmail.com Kyle Baron - ky...@metrumrg.com Or join the discussion in the Biorxiv category thread on http://discuss.go-isop.org/ Best regards, Vijay Ivaturi Kyle Baron -- ~Vijay
